Search

everythinglearnresearchcommunity

for

Search:↓

SLE and DM can coexist but are rare and need careful evaluation.

A group has developed therapies that show promise for treating cancer and various other conditions.

Caffeic acid helps protect rats from the harmful effects of acrylamide.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Pregnant women with hair loss often have low zinc and iron levels.

Low levels of vitamin B12, ferritin, and calcium are linked to premature graying of hair.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Low-level laser therapy combined with Neoptide improved hair regrowth better than either treatment alone in rats.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Zinc oxide nanoparticles in sunscreen do not penetrate deep into the skin.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.